| 0 |
EAR, NOSE AND THROAT INFECTION |
1 |
0.0122 |
| 1 |
SINUSITIS BACTERIAL |
1 |
0.0009 |
| 2 |
NASAL PRURITUS |
1 |
0.0008 |
| 3 |
CARBON DIOXIDE INCREASED |
1 |
0.0007 |
| 4 |
HEAD TITUBATION |
1 |
0.0007 |
| 5 |
MULTI-ORGAN DISORDER |
1 |
0.0005 |
| 6 |
DRUG DELIVERY SYSTEM ISSUE |
1 |
0.0005 |
| 7 |
RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0004 |
| 8 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 9 |
OBSTRUCTION |
1 |
0.0003 |
| 10 |
NASAL POLYPS |
1 |
0.0002 |
| 11 |
INCREASED UPPER AIRWAY SECRETION |
1 |
0.0002 |
| 12 |
FAECALOMA |
1 |
0.0002 |
| 13 |
PLEURISY |
1 |
0.0002 |
| 14 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 15 |
GROIN PAIN |
1 |
0.0001 |
| 16 |
MIDDLE INSOMNIA |
2 |
0.0001 |
| 17 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 18 |
SKIN INFECTION |
1 |
0.0001 |
| 19 |
EYE INFECTION |
1 |
0.0001 |
| 20 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 21 |
MADAROSIS |
1 |
0.0001 |
| 22 |
CARDIOMEGALY |
1 |
0.0001 |
| 23 |
CYST |
1 |
0.0001 |
| 24 |
TACHYPNOEA |
1 |
0.0001 |
| 25 |
BRONCHOSPASM |
1 |
0.0001 |
| 26 |
INSURANCE ISSUE |
1 |
0.0001 |
| 27 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 28 |
VIRAL INFECTION |
2 |
0.0001 |
| 29 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 30 |
SINUS DISORDER |
1 |
0.0001 |
| 31 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 32 |
DERMATITIS |
1 |
0.0000 |
| 33 |
RASH PAPULAR |
1 |
0.0000 |
| 34 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 35 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 36 |
EAR INFECTION |
1 |
0.0000 |
| 37 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 38 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 39 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 40 |
APHASIA |
1 |
0.0000 |
| 41 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 42 |
HYPOXIA |
1 |
0.0000 |
| 43 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 44 |
SEIZURE |
3 |
0.0000 |
| 45 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 46 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 47 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 48 |
HEART RATE INCREASED |
2 |
0.0000 |
| 49 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 50 |
CHILLS |
2 |
0.0000 |
| 51 |
NASAL CONGESTION |
1 |
0.0000 |
| 52 |
WHEEZING |
1 |
0.0000 |
| 53 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 54 |
SLEEP DISORDER |
1 |
0.0000 |
| 55 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 56 |
BRONCHITIS |
1 |
0.0000 |
| 57 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 58 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 59 |
TACHYCARDIA |
1 |
0.0000 |
| 60 |
CARDIAC DISORDER |
1 |
0.0000 |
| 61 |
MIGRAINE |
1 |
0.0000 |
| 62 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 63 |
SINUSITIS |
1 |
0.0000 |
| 64 |
ILLNESS |
1 |
0.0000 |
| 65 |
HYPERTENSION |
2 |
0.0000 |
| 66 |
INFLUENZA |
1 |
0.0000 |
| 67 |
ASTHMA |
1 |
0.0000 |
| 68 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 69 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 70 |
INFECTION |
1 |
0.0000 |
| 71 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 72 |
PYREXIA |
2 |
0.0000 |
| 73 |
COVID-19 |
1 |
0.0000 |
| 74 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 75 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 76 |
CHEST PAIN |
1 |
0.0000 |
| 77 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 78 |
ASTHENIA |
2 |
0.0000 |
| 79 |
HYPOTENSION |
1 |
0.0000 |
| 80 |
SOMNOLENCE |
1 |
0.0000 |
| 81 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 82 |
DECREASED APPETITE |
1 |
0.0000 |
| 83 |
DYSPNOEA |
2 |
0.0000 |
| 84 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 85 |
HEADACHE |
2 |
0.0000 |
| 86 |
PNEUMONIA |
1 |
0.0000 |
| 87 |
FALL |
1 |
0.0000 |
| 88 |
DIZZINESS |
1 |
0.0000 |
| 89 |
PAIN |
1 |
0.0000 |
| 90 |
FATIGUE |
1 |
0.0000 |
| 91 |
NAUSEA |
1 |
0.0000 |